Found: 33
Select item for more details and to access through your institution.
Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4687, doi. 10.3390/ijms22094687
- By:
- Publication type:
- Article
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 2, p. 329, doi. 10.1007/s10549-018-4766-2
- By:
- Publication type:
- Article
Charting differentially methylated regions in cancer with Rocker-meth.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02761-3
- By:
- Publication type:
- Article
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06).
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919891608
- By:
- Publication type:
- Article
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00382-5
- By:
- Publication type:
- Article
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0092-4
- By:
- Publication type:
- Article
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 12, p. 1677, doi. 10.3390/biom10121677
- By:
- Publication type:
- Article
RAI(ShcC/N-Shc)-dependent recruitment of GAB1 to RET oncoproteins potentiates PI3-K signalling in thyroid tumors.
- Published in:
- Oncogene, 2005, v. 24, n. 41, p. 6303, doi. 10.1038/sj.onc.1208776
- By:
- Publication type:
- Article
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
- Published in:
- Oncogene, 2003, v. 22, n. 2, p. 246, doi. 10.1038/sj.onc.1206112
- By:
- Publication type:
- Article
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2762, doi. 10.3390/cancers13112762
- By:
- Publication type:
- Article
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2640, doi. 10.3390/cancers13112640
- By:
- Publication type:
- Article
The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1894, doi. 10.3390/cancers11121894
- By:
- Publication type:
- Article
Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?
- Published in:
- Cancers, 2014, v. 6, n. 2, p. 684, doi. 10.3390/cancers6020684
- By:
- Publication type:
- Article
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 123, n. 3, p. 651, doi. 10.1007/s10549-009-0632-6
- By:
- Publication type:
- Article
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918815591
- By:
- Publication type:
- Article
The role of abemaciclib in treatment of advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918776925
- By:
- Publication type:
- Article
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response.
- Published in:
- Breast Care, 2017, v. 12, n. 5, p. 304, doi. 10.1159/000484167
- By:
- Publication type:
- Article
Is There Still a Role for First-Line Single Agent Endocrine Therapy in HR+ and HER2- Advanced Breast Cancer?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
- Published in:
- Briefings in Bioinformatics, 2023, v. 24, n. 2, p. 1, doi. 10.1093/bib/bbad015
- By:
- Publication type:
- Article
Exploring Serum NMR-Based Metabolomic Fingerprint of Colorectal Cancer Patients: Effects of Surgery and Possible Associations with Cancer Relapse.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 23, p. 11120, doi. 10.3390/app112311120
- By:
- Publication type:
- Article
Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00666
- By:
- Publication type:
- Article
Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Glucose Metabolic Reprogramming of ER+ Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 3, p. 668, doi. 10.3390/cells9030668
- By:
- Publication type:
- Article
ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data.
- Published in:
- BMC Genomics, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s12864-018-5249-x
- By:
- Publication type:
- Article
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.
- Published in:
- Molecular & Clinical Oncology, 2020, v. 12, n. 5, p. 456, doi. 10.3892/mco.2020.2016
- By:
- Publication type:
- Article
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancer.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 736, p. 1, doi. 10.1126/scitranslmed.adf9874
- By:
- Publication type:
- Article
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers.
- Published in:
- BMC Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12916-015-0280-0
- By:
- Publication type:
- Article
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt337
- By:
- Publication type:
- Article
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 4, p. 749, doi. 10.1016/j.molonc.2014.12.001
- By:
- Publication type:
- Article